AAAAAA

   
Results: 1-16 |
Results: 16
Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant
Authors: Marotta, F Safran, P Tajiri, H Princess, G Anzulovic, H Ideo, GM Rouge, A Seal, MG Ideo, G
Citation: F. Marotta et al., Improvement of hemorheological abnormalities in alcoholics by an oral antioxidant, HEP-GASTRO, 48(38), 2001, pp. 511-517
Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C
Authors: Bruno, S Battezzati, PM Bellati, G Manzin, A Maggioni, M Crosignani, A Borzio, M Solforosi, L Morabito, A Ideo, G Podda, M
Citation: S. Bruno et al., Long-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis C, J HEPATOL, 34(5), 2001, pp. 748-755
Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation
Authors: Belli, LS Zavaglia, C Alberti, AB Poli, F Rondinara, G Silini, E Taioli, E de Carlis, L Scalamogna, M Forti, D Pinzello, G Ideo, G
Citation: Ls. Belli et al., Influence of immunogenetic background on the outcome of recurrent hepatitis C after liver transplantation, HEPATOLOGY, 31(6), 2000, pp. 1345-1350
Cyanocobalamin absorption abnormality in alcoholics is improved by oral supplementation with a fermented papaya-derived antioxidant
Authors: Marotta, F Tajiri, H Barreto, R Brasca, P Ideo, GM Mondazzi, L Safran, P Bobadilla, J Ideo, G
Citation: F. Marotta et al., Cyanocobalamin absorption abnormality in alcoholics is improved by oral supplementation with a fermented papaya-derived antioxidant, HEP-GASTRO, 47(34), 2000, pp. 1189-1194
Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy
Authors: Bellobuono, A Mondazzi, L Tempini, S Chiodo, F Magliano, E Furione, L Ideo, G
Citation: A. Bellobuono et al., Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy, J HEPATOL, 33(3), 2000, pp. 463-468
A randomized, controlled study of thymosin-alpha(1) therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B
Authors: Zavaglia, C Severini, R Tinelli, C Franzone, JS Airoldi, A Tempini, S Bettale, G Ideo, G
Citation: C. Zavaglia et al., A randomized, controlled study of thymosin-alpha(1) therapy in patients with anti-HBe, HBV-DNA-positive chronic hepatitis B, DIG DIS SCI, 45(4), 2000, pp. 690-696
Semiquantitative assessment of IgM antibody to hepatitis B core antigen and prediction of the severity of chronic hepatitis B
Authors: Colloredo, G Bellati, G Sonzogni, A Zavaglia, C Fracassetti, O Leandro, G Ghislandi, R Minola, E Ideo, G
Citation: G. Colloredo et al., Semiquantitative assessment of IgM antibody to hepatitis B core antigen and prediction of the severity of chronic hepatitis B, J VIRAL HEP, 6(6), 1999, pp. 429-434
Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy
Authors: Colloredo, G Roffi, L Brunetto, MR Leandro, G Brugnetti, B Bissoli, F Scalori, A Mancia, G Civardi, E Ideo, G Bonino, F Bellati, G
Citation: G. Colloredo et al., Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy, J VIRAL HEP, 6(5), 1999, pp. 373-380
Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis
Authors: Baudo, F Caimi, TM Redaelli, R De Cataldo, F Somaini, G Rondinara, GF Degasperi, A Bellati, G Belli, LS Ideo, G Morfini, M Longo, G
Citation: F. Baudo et al., Orthotopic liver transplantation in a patient with severe haemophilia A and with advanced liver cirrhosis, HAEMOPHILIA, 5(4), 1999, pp. 276-277
Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study
Authors: Ideo, G Bellobuono, A Tempini, S Mondazzi, L Airoldi, A Benetti, G Bissoli, F Cestari, C Colombo, E Del Poggio, P Fracassetti, O Lazzaroni, S Marelli, A Paris, B Prada, A Rainer, E Roffi, L
Citation: G. Ideo et al., Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone: a randomized, multicentre study, EUR J GASTR, 11(11), 1999, pp. 1203-1207
Human leukocyte antigen class II and III alleles and severity of hepatitisC virus-related chronic liver disease
Authors: Asti, M Martinetti, M Zavaglia, C Cuccia, MC Gusberti, L Tinelli, C Cividini, A Bruno, S Salvaneschi, L Ideo, G Mondelli, MU Silini, EM
Citation: M. Asti et al., Human leukocyte antigen class II and III alleles and severity of hepatitisC virus-related chronic liver disease, HEPATOLOGY, 29(4), 1999, pp. 1272-1279
Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?
Authors: Bellobuono, A Mondazzi, L Tempini, S Chiodo, F Magliano, E Mondini, C Ideo, G
Citation: A. Bellobuono et al., Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?, J HEPATOL, 30(1), 1999, pp. 8-13
Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation
Authors: Belli, LS Zavaglia, C Alberti, AB Rondinara, GF De Carlis, L Silini, E Poli, F Scalamogna, M Tinelli, G Forti, D Ideo, G
Citation: Ls. Belli et al., Immunogenetic factors, HCV genotypes, and HCV recurrence after liver transplantation, TRANSPLAN P, 31(1-2), 1999, pp. 483-484
Ethanol-related gastric mucosal damage: Evidence of a free radical-mediated mechanism and beneficial effect of oral supplementation with bionormalizer, a novel natural antioxidant
Authors: Marotta, F Tajiri, H Safran, P Fesce, E Ideo, G
Citation: F. Marotta et al., Ethanol-related gastric mucosal damage: Evidence of a free radical-mediated mechanism and beneficial effect of oral supplementation with bionormalizer, a novel natural antioxidant, DIGESTION, 60(6), 1999, pp. 538-543
Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon
Authors: Oliveri, F Santantonio, T Bellati, G Colombatto, P Mels, GC Carriero, L Dastoli, G Pastore, G Ideo, G Bonino, F Brunetto, MR
Citation: F. Oliveri et al., Long term response to therapy of chronic anti-HBe-positive hepatitis B is poor independent of type and schedule of interferon, AM J GASTRO, 94(5), 1999, pp. 1366-1372
Lamivudine treatment for acute hepatitis B after liver transplantation
Authors: Andreone, P Caraceni, P Grazi, GL Belli, L Milandri, GL Ercolani, G Jovine, E D'Errico, A Dal Monte, PR Ideo, G Forti, D Mazziotti, A Cavallari, A Bernardi, M
Citation: P. Andreone et al., Lamivudine treatment for acute hepatitis B after liver transplantation, J HEPATOL, 29(6), 1998, pp. 985-989
Risultati: 1-16 |